Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - Loss AllowanceNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Other Non-Current Liabilities: 2011-2016

Historic Other Non-Current Liabilities for RedHill Biopharma (RDHL) over the last 6 years, with Dec 2016 value amounting to $1.1 million.

  • RedHill Biopharma's Other Non-Current Liabilities changed negligibly% to $1.1 million in Q4 2016 from the same period last year, while for Dec 2016 it was $1.1 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $1.1 million for FY2016, which is negligibly% changed negligibly from last year.
  • RedHill Biopharma's Other Non-Current Liabilities amounted to $1.1 million in FY2016, which was down 0.00% from $1.1 million recorded in FY2015.
  • Over the past 5 years, RedHill Biopharma's Other Non-Current Liabilities peaked at $3.3 million during FY2012, and registered a low of $1.1 million during FY2015.
  • For the 3-year period, RedHill Biopharma's Other Non-Current Liabilities averaged around $1.2 million, with its median value being $1.1 million (2016).
  • As far as peak fluctuations go, RedHill Biopharma's Other Non-Current Liabilities climbed by 21.85% in 2012, and later tumbled by 42.96% in 2013.
  • Over the past 5 years, RedHill Biopharma's Other Non-Current Liabilities (Yearly) stood at $3.3 million in 2012, then tumbled by 42.96% to $1.9 million in 2013, then dropped by 18.16% to $1.5 million in 2014, then slumped by 30.82% to $1.1 million in 2015, then remained steady at $1.1 million in 2016.